Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim Clinical Trial

Official title: Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

Status Active, not recruiting

Clinical Trial Summary

To evaluate the difference in the incidence of febrile episodes in patients undergoing stem cells mobilization with chemotherapy and filgrastim versus chemotherapy and lenograstim.

A febrile episode will be considered as: body temperature > 38°C for two measurements in the 24 hours with an interval of 6 hours at least between the two measurements.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Fever
• G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim
• Multiple Myeloma
• Neoplasms, Plasma Cell

• NCT number: NCT00932217
• Study type: Interventional
• Source: University of Pisa
• Status: Active, not recruiting
• Phase: Phase 3
• Start date: December 2004